More on Biosecurity
WASHINGTON, D.C. — Today, Chairman John Moolenaar (R-MI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the U.S. and the Chinese Communist Party and House Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup D.P.M. (R-OH) released the below statement following the 40 to 1 vote by the House Oversight Committee to advance the BIOSECURE Act the House floor.
WASHINGTON, D.C. — Today, Chairman John Moolenaar (R-MI) of the House Select Committee on the Chinese Communist Party joined Ranking Member Raja Krishnamoorthi (D-IL), and Rep. Brad Wenstrup (R-OH) to introduce the bipartisan BIOSECURE Act, a bill to ensure American patient data and taxpayer dollars do not fall into the hands of foreign adversaries' biotechnology companies of concern by prohibiting Federal contracting with these companies.
Chairman John Moolenaar (R-MI) of the House Select Committee on the Chinese Communist Party joined Ranking Member Raja Krishnamoorthi (D-IL), and Rep.
Full transcript of the hearing HERE.
|
WATCH: Video summary of the Select Committee's findings on the CCP's role in the American fentanyl epidemic.
WATCH: Video summary of the Select Committee's findings on the CCP's role in the American fentanyl epidemic. (Click HERE for a transcript of the video)
Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party wrote to Secretary of Defense Lloyd Austin, alerting him that a Chinese military company, BGI, is attempting to set up a new firm, Innomics, in Massachusetts and Kentucky, to avoid regulatory scrutiny. The lawmakers also identify other problematic Chinese biotech companies in the U.S.
WASHINGTON, D.C.-- Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party wrote to Secretary of Defense Lloyd Austin, alerting him that a Chinese military company, BGI, is attempting to set up a new firm, Innomics, in Massachusetts and Kentucky, to avoid regulatory scrutiny. The lawmakers also identify other problematic Chinese biotech companies in the U.S. that are working to advance the Chinese military and the Chinese Communist Party’s objectives and goals.
